Dorsey Wright & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Dorsey Wright & Associates's EW Position: Q1 2021 in Review
Dorsey Wright & Associates sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 30,204 shares — an estimated $2.76M sold.
Dorsey Wright & Associates first reported a position in EW in Q4 2014 and held it in 15 quarters. The position peaked at $5.11M in Q3 2016. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.
- Dorsey Wright & Associates reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
- Dorsey Wright & Associates sold 30,204 Edwards Lifesciences shares in Q1 2021, an estimated $2.76M.
- Dorsey Wright & Associates first reported a position in Edwards Lifesciences in Q4 2014 and held it in 15 quarters.
- Dorsey Wright & Associates's Edwards Lifesciences position peaked at $5.11M in Q3 2016.
- 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.
Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.